A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas
Clinical trial NCT01118377 · COMPLETED
Trial details
- NCT number
- NCT01118377
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.